Home
VSTM
VSTM News

Latest Verastem Inc. (VSTM) News on July 8, 2024

Verastem Oncology Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Business Wire

6 hours ago

Verastem Oncology Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

MT Newswires

8 hours ago

Truist Securities Adjusts Price Target on Verastem to $18 From $34, Notes Recent Stock Pull Back; Maintains Buy Rating

Verastem Oncology Announces Addition to Russell 3000® and Russell Microcap® Indexes

Business Wire

7 days ago

Verastem Oncology Announces Addition to Russell 3000® and Russell Microcap® Indexes

MT Newswires

a month ago

RBC Halves Price Target on Verastem to $16 From $32, Maintains Outperform Rating, Speculative Risk Qualifier

MT Newswires

a month ago

Top Midday Decliners

Verastem (VSTM) Up on Upbeat Early Pancreatic Cancer Study Data

Zacks

a month ago

Verastem (VSTM) Up on Upbeat Early Pancreatic Cancer Study Data

What's Going On With Mid-Cap Cancer-Focused Verastem Oncology Stock On Friday?

Benzinga

a month ago

What's Going On With Mid-Cap Cancer-Focused Verastem Oncology Stock On Friday?

MT Newswires

a month ago

Sector Update: Health Care Stocks Advance Pre-Bell Friday

ASCO 2024: Verastem’s combo therapy for pancreatic cancer hits early trial success

Pharmaceutical Technology

a month ago

ASCO 2024: Verastem’s combo therapy for pancreatic cancer hits early trial success

ASCO 2024: Verastem’s combo therapy for pancreatic cancer hits early trial success

Clinical Trials Arena

a month ago

ASCO 2024: Verastem’s combo therapy for pancreatic cancer hits early trial success

MT Newswires

a month ago

Verastem Reports Results of Potential Pancreatic Cancer Treatment, Submits Rolling New Drug Application for Rare Ovarian Cancer

Verastem Oncology Announces the Initiation of a Rolling Submission of NDA to FDA Seeking Accelerated Approval of Avutometinib and Defactinib Combination for the Treatment of Adult Patients with Recurrent KRAS Mutant Low-Grade Serous Ovarian Cancer

Business Wire

a month ago

Verastem Oncology Announces the Initiation of a Rolling Submission of NDA to FDA Seeking Accelerated Approval of Avutometinib and Defactinib Combination for the Treatment of Adult Patients with Recurrent KRAS Mutant Low-Grade Serous Ovarian Cancer

Verastem Oncology Announces Positive Initial Interim Safety and Efficacy Results from RAMP 205 Trial Evaluating Avutometinib Plus Defactinib in Combination with Gemcitabine and Nab-paclitaxel in First-Line Metastatic Pancreatic Cancer

Business Wire

a month ago

Verastem Oncology Announces Positive Initial Interim Safety and Efficacy Results from RAMP 205 Trial Evaluating Avutometinib Plus Defactinib in Combination with Gemcitabine and Nab-paclitaxel in First-Line Metastatic Pancreatic Cancer

Associated Press Finance

2 months ago

Verastem: Q1 Earnings Snapshot

Verastem Oncology Reports First Quarter 2024 Financial Results and Highlights Recent Business Updates

Business Wire

2 months ago

Verastem Oncology Reports First Quarter 2024 Financial Results and Highlights Recent Business Updates

Verastem Oncology to Present at the RBC Capital Markets Global Healthcare Conference

Business Wire

2 months ago

Verastem Oncology to Present at the RBC Capital Markets Global Healthcare Conference

Verastem Oncology Announces Appointment of John Hayslip, M.D., to Chief Medical Officer

Business Wire

3 months ago

Verastem Oncology Announces Appointment of John Hayslip, M.D., to Chief Medical Officer

Verastem Oncology Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Business Wire

3 months ago

Verastem Oncology Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Global Patient Survey Results Reveal Significant Negative Impact on Social, Emotional and Mental Well-Being for People Living with Low-Grade Serous Ovarian Cancer

Business Wire

4 months ago

Global Patient Survey Results Reveal Significant Negative Impact on Social, Emotional and Mental Well-Being for People Living with Low-Grade Serous Ovarian Cancer

Associated Press Finance

4 months ago

Verastem: Q4 Earnings Snapshot

Verastem Oncology Reports Fourth Quarter and Full Year 2023 Financial Results and Highlights Recent Business Updates

Business Wire

4 months ago

Verastem Oncology Reports Fourth Quarter and Full Year 2023 Financial Results and Highlights Recent Business Updates

Verastem Oncology Announces Multiple Oral Presentations at SGO 2024 Annual Meeting on Women’s Cancer that Highlight Advances in Low-Grade Serous Ovarian Cancer Research and Reinforce Commitment to Addressing Urgent Unmet Needs

Business Wire

4 months ago

Verastem Oncology Announces Multiple Oral Presentations at SGO 2024 Annual Meeting on Women’s Cancer that Highlight Advances in Low-Grade Serous Ovarian Cancer Research and Reinforce Commitment to Addressing Urgent Unmet Needs

Verastem Oncology Receives Orphan Drug Designation from FDA for Avutometinib Alone or in Combination With Defactinib in Recurrent Low-Grade Serous Ovarian Cancer

Business Wire

4 months ago

Verastem Oncology Receives Orphan Drug Designation from FDA for Avutometinib Alone or in Combination With Defactinib in Recurrent Low-Grade Serous Ovarian Cancer

Verastem Oncology Announces Preclinical Presentations for New Oral G12D Inhibitor and for Avutometinib and Defactinib Combination as a Backbone of Therapy for RAS/MAPK Driven Cancers at AACR Annual Meeting 2024

Business Wire

4 months ago

Verastem Oncology Announces Preclinical Presentations for New Oral G12D Inhibitor and for Avutometinib and Defactinib Combination as a Backbone of Therapy for RAS/MAPK Driven Cancers at AACR Annual Meeting 2024

Andreas Halvorsen's Viking Global Investors LP Bolsters Position in Verastem Inc

GuruFocus.com

5 months ago

Andreas Halvorsen's Viking Global Investors LP Bolsters Position in Verastem Inc

Director Robert Gagnon Sells 9,204 Shares of Verastem Inc (VSTM)

GuruFocus.com

5 months ago

Director Robert Gagnon Sells 9,204 Shares of Verastem Inc (VSTM)

3 Stocks That AI Predicts Will Deliver Triple-Digit Returns This Year: February 2024

InvestorPlace

5 months ago

3 Stocks That AI Predicts Will Deliver Triple-Digit Returns This Year: February 2024

GCM Grosvenor to Announce Fourth Quarter and Full Year 2023 Financial Results and Host Investor Conference Call on February 13, 2024

GlobeNewswire

5 months ago

GCM Grosvenor to Announce Fourth Quarter and Full Year 2023 Financial Results and Host Investor Conference Call on February 13, 2024

Verastem Oncology Outlines Key 2024 Strategic Priorities and Upcoming Catalysts for Advancing Avutometinib and Defactinib and Broader Pipeline in RAS Pathway-Driven Cancers

Business Wire

5 months ago

Verastem Oncology Outlines Key 2024 Strategic Priorities and Upcoming Catalysts for Advancing Avutometinib and Defactinib and Broader Pipeline in RAS Pathway-Driven Cancers

LSI Industries (NASDAQ:LYTS) Has Affirmed Its Dividend Of $0.05

Simply Wall St.

5 months ago

LSI Industries (NASDAQ:LYTS) Has Affirmed Its Dividend Of $0.05

Blackstone and Other Asset Manager Stocks Have Soared. Earnings Shouldn’t Disappoint.

Barrons.com

5 months ago

Blackstone and Other Asset Manager Stocks Have Soared. Earnings Shouldn’t Disappoint.

MarineMax Inc (HZO) Reports Record Q1 Revenue Amidst Retail Challenges

GuruFocus.com

5 months ago

MarineMax Inc (HZO) Reports Record Q1 Revenue Amidst Retail Challenges

Heron (HRTX) Gains 19% on FDA Nod for Zynrelef Label Expansion

Zacks

5 months ago

Heron (HRTX) Gains 19% on FDA Nod for Zynrelef Label Expansion

Cathay General (CATY) Beats Q4 Earnings and Revenue Estimates

Zacks

5 months ago

Cathay General (CATY) Beats Q4 Earnings and Revenue Estimates

Magic Software Enterprises Ltd.'s (NASDAQ:MGIC) Stock Has Fared Decently: Is the Market Following Strong Financials?

Simply Wall St.

5 months ago

Magic Software Enterprises Ltd.'s (NASDAQ:MGIC) Stock Has Fared Decently: Is the Market Following Strong Financials?

CONSOL Energy (CEIX) Returned 61% Despite 25% Fall in Estimates

Insider Monkey

5 months ago

CONSOL Energy (CEIX) Returned 61% Despite 25% Fall in Estimates

American Coastal Insurance Reaches US$505m Market Cap Benefiting Insider Stock Buying

Simply Wall St.

6 months ago

American Coastal Insurance Reaches US$505m Market Cap Benefiting Insider Stock Buying

Verastem (VSTM) Up 8% on Fast Track Tag for NSCLC Combo Therapy

Zacks

6 months ago

Verastem (VSTM) Up 8% on Fast Track Tag for NSCLC Combo Therapy

Consolidated Communications Reminds Shareholders to Vote FOR the Value Maximizing Transaction Today

Business Wire

6 months ago

Consolidated Communications Reminds Shareholders to Vote FOR the Value Maximizing Transaction Today

Baijiayun Announces Changes in Management and Board of Directors

PR Newswire

6 months ago

Baijiayun Announces Changes in Management and Board of Directors

Reuters

6 months ago

CORRECTED-SEC probes B. Riley deals with client tied to failed hedge fund - Bloomberg News

When Will Invivyd, Inc. (NASDAQ:IVVD) Become Profitable?

Simply Wall St.

6 months ago

When Will Invivyd, Inc. (NASDAQ:IVVD) Become Profitable?

Verastem Oncology Granted Fast Track Designation for Combination of Avutometinib and Sotorasib for the Treatment of KRAS G12C-Mutant Non-Small Cell Lung Cancer (NSCLC)

Business Wire

6 months ago

Verastem Oncology Granted Fast Track Designation for Combination of Avutometinib and Sotorasib for the Treatment of KRAS G12C-Mutant Non-Small Cell Lung Cancer (NSCLC)

Why Calavo Growers (CVGW) Stock Is Trading Lower Today

StockStory

6 months ago

Why Calavo Growers (CVGW) Stock Is Trading Lower Today

NEUBERGER BERMAN MUNICIPAL FUND ANNOUNCES MONTHLY DISTRIBUTION

PR Newswire

6 months ago

NEUBERGER BERMAN MUNICIPAL FUND ANNOUNCES MONTHLY DISTRIBUTION

Chatham Lodging Trust Announces Fourth Quarter Earnings Call to be Held on Tuesday, February 27, 2024

Business Wire

6 months ago

Chatham Lodging Trust Announces Fourth Quarter Earnings Call to be Held on Tuesday, February 27, 2024

Verastem Oncology to Participate in the B. Riley Securities 4th Annual Oncology Conference

Business Wire

6 months ago

Verastem Oncology to Participate in the B. Riley Securities 4th Annual Oncology Conference

abrdn U.S. Closed-End Funds Announce Distribution Payment Details

ACCESSWIRE

6 months ago

abrdn U.S. Closed-End Funds Announce Distribution Payment Details

Taseko Announces a 26% Increase in Annual Copper Production from its Gibraltar Mine

PR Newswire

6 months ago

Taseko Announces a 26% Increase in Annual Copper Production from its Gibraltar Mine

Roadzen Appoints Jean-Noël Gallardo as Global Chief Financial Officer

GlobeNewswire

6 months ago

Roadzen Appoints Jean-Noël Gallardo as Global Chief Financial Officer

Business Wire

6 months ago

Xponential Fitness, Inc. Provides 2023 Operating Highlights

Owning 48% shares,institutional owners seem interested in Aura Biosciences, Inc. (NASDAQ:AURA),

Simply Wall St.

6 months ago

Owning 48% shares,institutional owners seem interested in Aura Biosciences, Inc. (NASDAQ:AURA),

Praxis Precision Medicines Announces Licensing and Collaboration Agreement with Tenacia Biotechnology for Ulixacaltamide in Greater China

GlobeNewswire

6 months ago

Praxis Precision Medicines Announces Licensing and Collaboration Agreement with Tenacia Biotechnology for Ulixacaltamide in Greater China

Verastem Oncology Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Business Wire

6 months ago

Verastem Oncology Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Resources Connection Inc (RGP) Faces Revenue Decline Amid Economic Challenges in Q2 Fiscal 2024

GuruFocus.com

6 months ago

Resources Connection Inc (RGP) Faces Revenue Decline Amid Economic Challenges in Q2 Fiscal 2024

Nerdy to Participate in Needham Growth Conference

Business Wire

6 months ago

Nerdy to Participate in Needham Growth Conference

Zacks.com featured highlights include REX American Resources, Consolidated Water and Beacon Roofing Supply

Zacks

6 months ago

Zacks.com featured highlights include REX American Resources, Consolidated Water and Beacon Roofing Supply

Sprinklr (NYSE:CXM) Shareholders Will Want The ROCE Trajectory To Continue

Simply Wall St.

6 months ago

Sprinklr (NYSE:CXM) Shareholders Will Want The ROCE Trajectory To Continue

Viasat (VSAT) Launches Data Plans for Small-Scale Enterprises

Zacks

7 months ago

Viasat (VSAT) Launches Data Plans for Small-Scale Enterprises

Guaranty Bancshares, Inc. Declares Quarterly Cash Dividend

Business Wire

7 months ago

Guaranty Bancshares, Inc. Declares Quarterly Cash Dividend

Overseas Shipholding Group Installs Starlink Satellite Internet Service on Entire Fleet

Business Wire

7 months ago

Overseas Shipholding Group Installs Starlink Satellite Internet Service on Entire Fleet

Verastem Oncology Selects Oral KRAS G12D Inhibitor GFH375/VS-7375 as Lead Program in Discovery and Development Collaboration with GenFleet Therapeutics

Business Wire

7 months ago

Verastem Oncology Selects Oral KRAS G12D Inhibitor GFH375/VS-7375 as Lead Program in Discovery and Development Collaboration with GenFleet Therapeutics

Getting In Cheap On PlayAGS, Inc. (NYSE:AGS) Is Unlikely

Simply Wall St.

7 months ago

Getting In Cheap On PlayAGS, Inc. (NYSE:AGS) Is Unlikely

Full Video Coverage – Healthcare Trends, Financing, Future Directions in 2024 Panel at 3rd Palm Beach CorpGov Forum

CorpGov.com

7 months ago

Full Video Coverage – Healthcare Trends, Financing, Future Directions in 2024 Panel at 3rd Palm Beach CorpGov Forum

AGS Partners With Three Rivers Resort to Deliver An AGS-Exclusive Table Games Floor

GlobeNewswire

7 months ago

AGS Partners With Three Rivers Resort to Deliver An AGS-Exclusive Table Games Floor

3 Off-the-Beaten-Path Stocks Poised for Substantial Growth

InvestorPlace

7 months ago

3 Off-the-Beaten-Path Stocks Poised for Substantial Growth

Verastem Oncology Announces Initiation of a Confirmatory Phase 3 Trial of Avutometinib and Defactinib in Recurrent Low-Grade Serous Ovarian Cancer

Business Wire

7 months ago

Verastem Oncology Announces Initiation of a Confirmatory Phase 3 Trial of Avutometinib and Defactinib in Recurrent Low-Grade Serous Ovarian Cancer

Returns On Capital Signal Difficult Times Ahead For China Yuchai International (NYSE:CYD)

Simply Wall St.

7 months ago

Returns On Capital Signal Difficult Times Ahead For China Yuchai International (NYSE:CYD)

Insider Sell Alert: President and CEO Douglas Doerfler Sells 124,450 Shares of MaxCyte Inc (MXCT)

GuruFocus.com

7 months ago

Insider Sell Alert: President and CEO Douglas Doerfler Sells 124,450 Shares of MaxCyte Inc (MXCT)

Nuveen Launches Innovative Multi-Asset, Custom Direct Indexing Portfolio

PR Newswire

7 months ago

Nuveen Launches Innovative Multi-Asset, Custom Direct Indexing Portfolio

Will Weakness in Karat Packaging Inc.'s (NASDAQ:KRT) Stock Prove Temporary Given Strong Fundamentals?

Simply Wall St.

7 months ago

Will Weakness in Karat Packaging Inc.'s (NASDAQ:KRT) Stock Prove Temporary Given Strong Fundamentals?

GreenTree Hospitality Group Ltd. (NYSE:GHG) Q3 2023 Earnings Call Transcript

Insider Monkey

8 months ago

GreenTree Hospitality Group Ltd. (NYSE:GHG) Q3 2023 Earnings Call Transcript

3 Disruptive Stocks That Could Turn $500 into $5,000

InvestorPlace

8 months ago

3 Disruptive Stocks That Could Turn $500 into $5,000

Biotech Breakthroughs: 3 Revolutionary Stocks Redefining Healthcare

InvestorPlace

8 months ago

Biotech Breakthroughs: 3 Revolutionary Stocks Redefining Healthcare

GuruFocus.com

8 months ago

Abacus Life Inc (ABL) Reports 20% Revenue Growth in Q3 2023

Abacus Life Reports Third Quarter 2023 Results

GlobeNewswire

8 months ago

Abacus Life Reports Third Quarter 2023 Results

Karat Packaging Inc. (NASDAQ:KRT) Q3 2023 Earnings Call Transcript

Insider Monkey

8 months ago

Karat Packaging Inc. (NASDAQ:KRT) Q3 2023 Earnings Call Transcript

Excelerate Energy, Inc. (NYSE:EE) Q3 2023 Earnings Call Transcript

Insider Monkey

8 months ago

Excelerate Energy, Inc. (NYSE:EE) Q3 2023 Earnings Call Transcript

Phathom Pharmaceuticals Inc (PHAT) Reports Q3 2023 Financial Results

GuruFocus.com

8 months ago

Phathom Pharmaceuticals Inc (PHAT) Reports Q3 2023 Financial Results

Abacus Life to Participate in the Stephens Investment Conference

GlobeNewswire

8 months ago

Abacus Life to Participate in the Stephens Investment Conference

Associated Press Finance

8 months ago

NLight: Q3 Earnings Snapshot

GuruFocus.com

8 months ago

The FTAI Infrastructure Inc (FIP) Company: A Short SWOT Analysis

Share on Social Networks: